Results 151 to 160 of about 16,213 (201)

PANDEMIA E PRODUTIVIDADE: DESENVOLVIMENTO DE CURSO EAD EM HEMATOLOGIA

Hematology, Transfusion and Cell Therapy, 2020
L. S. Barros, I. S. Mesquita, F. M. Arruda, E. R. M. Gurgel, V. F. Bezerra, D. Alencar, L. G. Albuquerque, G. B. Lima, A. Araújo, F. S. D. Santos   +9 more
semanticscholar   +1 more source

Effectiveness of intraoperative blood recovery in surgical patients at risk of transfusion: A rapid review. [PDF]

Hematol Transfus Cell Ther
Uchimura LYT, Yonekura T, Quintans JR, Figueiró MF, Murador P, de Carvalho MA.   +5 more
europepmc   +1 more source

Systematic Duffy phenotyping reveals high prevalence of Duffy-null genotype among neutropenic patients. [PDF]

Adv Lab Med
Sierra LS, Núñez NF, Querol MS, Arnall AM.   +3 more
europepmc   +1 more source

Protocolo ALLIC-BFM 2002 en el Instituto de Hematologia e Inmunologia: experiencia de 10 añosDecember 21, 2015

Revista Cubana de Hematología, Inmunología y Hemoterapia
Alejandro González Otero, Alberto Arencibia Núñez, Sergio Machín García, Andrea Menéndez Veitía, Adys Gutiérrez Díaz, Ileana Nordet Carrera, Jesús Serrano Mirabal, Valia Pavón Morán, Maryuri Villatoro Villatoro, Eva Svarch, Consuelo Macías Abraham, Ana María Amor Vigil, Kalia Lavaut Sánchez, Vianed Marsán Suárez, Rosa María Lam Díaz   +14 more
doaj  

Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study. [PDF]

Am J Hematol
Aspas Requena G, Montesinos P, Bérard E, Bertoli S, Rodríguez-Veiga R, Simand C, Torres L, Peterlin P, Tormo M, Birsen R, Bergua-Burgues JM, Tavernier E, Bernal Del Castillo T, Carré M, Gil C, Contejean A, Rodríguez-Arbolí E, Orvain C, Rodríguez-Medina C, Veronese L, Sayas Lloris MJ, Delabesse E, Serrano J, Mineur A, García-Fortes M, Guieze R, Amigo ML, Pigneux A, Algarra Algarra L, Recher C, Dumas PY, Martínez-Cuadrón D.   +31 more
europepmc   +1 more source

MPL mutations are over-represented in patients with dual driver-mutated myeloproliferative neoplasms: an Irish cohort study. [PDF]

Hematol Transfus Cell Ther
Kearney L, Andrews C, Brodie R, Elhassadi E, Enright H, Fadalla K, Fay M, Flynn C, Fortune A, Hodgson A, Kumar S, Perera K, Sargent J, Smyth L, Langabeer SE.   +14 more
europepmc   +1 more source

Atypical chronic lymphocytic leukemia with biallelic 13Q deletion. [PDF]

Hematol Transfus Cell Ther
Roldán Galiacho V, Altuna Tellechea L, Alonso Varela M, Diez de Lezcano Manrique deLara I.   +3 more
europepmc   +1 more source

Is time to plasma exchange the right question in suspected thrombotic thrombocytopenic purpura? [PDF]

Hematol Transfus Cell Ther
Sinha RR.
europepmc   +1 more source

Innovations and Inequalities: The Challenge of Access in Multiple Myeloma Management in Brazil. [PDF]

Hematol Transfus Cell Ther
Ribeiro GN, Crusoé EQ, Maiolino A, Hungria VTM.   +3 more
europepmc   +1 more source

Psychosocial Outcomes and Quality of Life in Patients with Hemophilia a Without Inhibitors: The HemoLIFE Study. [PDF]

J Clin Med
Álvarez-Román MT, Núñez Vazquez RJ, Benítez Hidalgo O, Quintana Paris L, Entrena Ureña L, López Jaime FJ, De la Corte-Rodríguez H, García Dasí M, Bosch P, Álvarez Cuervo C, Guerra Garaeta I, Barras Sanchez V, Soto-Ortega I.   +12 more
europepmc   +1 more source